Drugging Drug Resistance

Cell

Volumn 141, Issue 1, 2010, Pages 18-20

  Dannenberg Jan Hermen, J H ^a   Berns, Anton ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 3; ERLOTINIB; HISTONE DEACETYLASE INHIBITOR;

CANCER CELL; CANCER CHEMOTHERAPY; CANCER RELAPSE; CANCER RESISTANCE; CELL SURVIVAL; CHROMATIN STRUCTURE; CLINICAL TRIAL; CROSS RESISTANCE; DNA DAMAGE; DNA METHYLATION; DNA MODIFICATION; DRUG MECHANISM; GENE MUTATION; GENETIC EPIGENESIS; HUMAN; LUNG NON SMALL CELL CANCER; PRIORITY JOURNAL; SHORT SURVEY;

EID: 77950924668     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cell.2010.03.020     Document Type: Short Survey

References (10)

1. Ahmed S., Palermo C., Wan S., Walworth N.C. Mol. Cell. Biol. 2004, 24:3660-3669.
2. Camphausen K., Tofilon P.J. J. Clin. Oncol. 2007, 25:4051-4056.
3. Engelman J.A., Jänne P.A. Clin. Cancer Res. 2008, 14:2895-2899.
4. Engelman J.A., Zejnullahu K., Mitsudomi T., Song Y., Hyland C., Park J.O., Lindeman N., Gale C.M., Zhao X., Christensen J., et al. Science 2007, 316:1039-1043.
5. Frank N.Y., Schatton T., Frank M.H. J. Clin. Invest. 2010, 120:41-50.
6. Klose R.J., Yan Q., Tothova Z., Yamane K., Erdjument-Bromage H., Tempst P., Gilliland D.G., Zhang Y., Kaelin W.G. Cell 2007, 128:889-900.
7. Lewis K. Nat. Rev. Microbiol. 2007, 5:48-56.
8. Peacock C.D., Watkins D.N. J. Clin. Oncol. 2008, 26:2883-2889.
9. Redmond K.M., Wilson T.R., Johnston P.G., Longley D.B. Front. Biosci. 2008, 13:5138-5154.
10. Sharma S.V., Lee D.Y., Li B., Quinlan M.P., Takahashi F., Maheswaran S., McDermott U., Azizian N., Zou L., Fischbach M.A., et al. Cell 2010, this issue.